Cargando...
Pathogen inactivation and removal methods for plasma‐derived clotting factor concentrates
Pathogen safety is crucial for plasma‐derived clotting factor concentrates used in the treatment of bleeding disorders. Plasma, the starting material for these products, is collected by plasmapheresis (source plasma) or derived from whole blood donations (recovered plasma). The primary measures rega...
Guardado en:
| Publicado en: | Transfusion |
|---|---|
| Autores principales: | , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
John Wiley and Sons Inc.
2013
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7169823/ https://ncbi.nlm.nih.gov/pubmed/24117799 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/trf.12423 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|